Literature DB >> 32131455

Left Atrial Structural Remodelling in Non-Valvular Atrial Fibrillation: What Have We Learnt from CMR?

Mariana Floria1,2, Smaranda Radu2,3, Evelina Maria Gosav2,4, Dragos Cozma5, Ovidiu Mitu2,6, Anca Ouatu2,4, Daniela Maria Tanase2,4, Viorel Scripcariu2,7, Lacramioara Ionela Serban2,8.   

Abstract

Left atrial structural, functional and electrical remodelling are linked to atrial fibrillation (AF) pathophysiology and mirror the phrase "AF begets AF". A structurally remodelled left atrium (LA) is fibrotic, dysfunctional and enlarged. Fibrosis is the hallmark of LA structural remodelling and is associated with increased risk of stroke, heart failure development and/or progression and poorer catheter ablation outcomes with increased recurrence rates. Moreover, increased atrial fibrosis has been associated with higher rates of stroke even in sinus-rhythm individuals. As such, properly assessing the fibrotic atrial cardiomyopathy in AF patients becomes necessary. In this respect, late-gadolinium enhancement cardiac magnetic resonance (LGE-CMR) imaging is the gold standard in imaging myocardial fibrosis. LA structural remodelling extension offers both diagnostic and prognostic information and influences therapeutic choices. LGE-CMR scans can be used before the procedure to better select candidates and to aid in choosing the ablation technique, during the procedure (full CMR-guided ablations) and after the ablation (to assess the ablation scar). This review focuses on imaging several LA structural remodelling CMR parameters, including size, shape and fibrosis (both extension and architecture) and their impact on procedure outcomes, recurrence risk, as well as their utility in relation to the index procedure timing.

Entities:  

Keywords:  atrial fibrillation; atrial fibrosis; cardiac magnetic resonance; structural remodeling

Year:  2020        PMID: 32131455     DOI: 10.3390/diagnostics10030137

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  3 in total

1.  Difference in left atrial D-dimer level in patients with atrial fibrillation treated with direct oral anticoagulant.

Authors:  Tetsuya Watanabe; Koichi Tachibana; Yukinori Shinoda; Tomoko Minamisaka; Hidetada Fukuoka; Hirooki Inui; Keisuke Ueno; Souki Inoue; Kentaro Mine; Shiro Hoshida
Journal:  BMC Cardiovasc Disord       Date:  2021-10-09       Impact factor: 2.298

2.  Influence of Sex-Based Differences in Cardiac Phenotype on Atrial Fibrillation Recurrence in Patients Undergoing Pulmonary Vein Isolation.

Authors:  Alena Yakimenka; Dina Labib; Steven Dykstra; Yoko Mikami; Alessandro Satriano; Jacqueline Flewitt; Patricia Feuchter; Sandra Rivest; Andrew G Howarth; Carmen P Lydell; F Russell Quinn; Stephen B Wilton; James A White
Journal:  Front Cardiovasc Med       Date:  2022-07-28

Review 3.  Latest Insights into Mechanisms behind Atrial Cardiomyopathy: It Is Not always about Ventricular Function.

Authors:  Bianca-Ana Dmour; Radu-Stefan Miftode; Dan Iliescu Halitchi; Dana Teodora Anton-Paduraru; Codruta-Olimpiada Iliescu Halitchi; Ionela-Larisa Miftode; Ovidiu Mitu; Alexandru-Dan Costache; Celina-Silvia Stafie; Irina Iuliana Costache
Journal:  Diagnostics (Basel)       Date:  2021-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.